Replies to post #176010 on Biotech Values

[DewDiligence]

EXEL—In other words, Cabozantinib is at best going to show middling efficacy in this indication.

[p3analyze]

By 0.75 You are assuming an overall alpha of 0.05. One can't rule oout 0.01 is being used instead.